JPRN-UMIN000049240尚未招募Unknown
Biomarker for malignant pleural mesothelioma - Biomarker for malignant pleural mesothelioma
Tokyo Womens Medical University, Tokyo, Japan0 个研究点目标入组 45 人开始时间: 2022年10月20日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients under 17 years old
研究者
相似试验
招募中
不适用
Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO)Pleural Mesothelioma MalignantNCT06637345Centro di Riferimento Oncologico - Aviano52
招募中
1 期
Optimising regulatory T cell depletion with cyclophosphamide in combination with chemotherapy for enhanced anti-tumour immunity in patients with non-small cell lung cancer (NSCLC) and malignant mesothelioma (MM).Malignant MesotheliomaNon small cell lung cancerCancer - Lung - MesotheliomaCancer - Lung - Non small cellACTRN12609000260224Sir Charles Gairdner Hospital33
已完成
不适用
The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural MesotheliomaPleural NeoplasmsMesotheliomaParathyroid NeoplasmsBenign Tumor of the ThyroidTumor of the ThyroidPneumothoraxNCT01776385Centre Hospitalier Universitaire de Nice9
已完成
不适用
Diagnostic accuracy of soluble mesothelin-related peptide in undiagnosed pleural effusions: a retrospective study in a single centermalignant pleural mesotheliomaJPRN-UMIN000024354Hyogo prefectural amagasaki general medical center300
Unknown
不适用
IP3R Modulation by Cancer Genes in MesotheliomaMalignant MesotheliomaNCT03558932KU Leuven20